Making a Difference with Early Identification and Treatment of Patients with NTRK Gene Fusions

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD; Arturo Loaiza-Bonilla, MD, MSEd, FACP

Video Categories: NTRK Gene Fusions

Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, explain the benefits of testing for TRK fusion–positive tumors early for improved clinical outcomes.

January 30, 2014

Personalized Medicine and Drug Development/Approval

Listen as Dr Agarwala presents how developments in personalized medicine will impact and change the way drugs are developed and approved.

September 20, 2013

Absorbing the Cost of Personalized Medicine

Matthew Palmgren discusses the benefits of personalized medicines